On March 13, 2025, the much-anticipated BIOCHINA 2025 (10th) International Convention kicked off at the Suzhou International Expo Center. The results of the BIOCHINA Awards 2024 were grandly announced at this expo. Shanghai Escugen Biotechnology Co., Ltd. was honored to be listed on the BIOCHINA Awards 2024 —— "Top 100 Innovative Breakthrough Enterprises" for its outstanding performance and great potential in the bio-pharmaceutical innovation and research field.

On December 10th, the "Top 50 Shanghai Startups with the Most Investment Potential in 2024" list was officially announced at the "Bund Finance·Shanghai International Equity Investment Forum." Shanghai Escugen Biotechnology Co., Ltd. (hereinafter referred to as "Escugen") was honored to be included on the list, marking another recognition of Escugen's scientific and technological innovation capabilities and investment potential by the industry.